Literature DB >> 23462821

Suggestions on the use of statistical methodologies in studies of the European Group for Blood and Marrow Transplantation.

Simona Iacobelli1.   

Abstract

This document explains some of the relevant methodological issues involved in planning a clinical study using survival and time-to-event outcome data, particularly in the field of haematopoietic stem cell transplantation, and indicates the appropriate statistical methods to use for the analysis. As the majority of these methods are commonly used in survival and event-history analysis, this document discusses their potential and limitations with reference to common SCT research situations. Some reference is given to methods, recently appearing in the literature that may be capable of handling complex investigations. These guidelines also address various practical issues, such as recoding or transforming variables in regression models or reporting results.

Mesh:

Year:  2013        PMID: 23462821     DOI: 10.1038/bmt.2012.282

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  53 in total

1.  Scripts for TRUMP data analyses. Part II (HLA-related data): statistical analyses specific for hematopoietic stem cell transplantation.

Authors:  Junya Kanda
Journal:  Int J Hematol       Date:  2015-11-20       Impact factor: 2.490

2.  Introduction of Transplant Registry Unified Management Program 2 (TRUMP2): scripts for TRUMP data analyses, part I (variables other than HLA-related data).

Authors:  Yoshiko Atsuta
Journal:  Int J Hematol       Date:  2015-11-07       Impact factor: 2.490

3.  The relationship between repeat resection and overall survival in patients with glioblastoma: a time-dependent analysis.

Authors:  Debra A Goldman; Koos Hovinga; Anne S Reiner; Yoshua Esquenazi; Viviane Tabar; Katherine S Panageas
Journal:  J Neurosurg       Date:  2018-11-01       Impact factor: 5.115

4.  Validation of a new integrated prognostic score to predict non-relapse mortality in patients undergoing reduced-intensity conditioning allogeneic hematopoietic cell transplantation.

Authors:  P Barba; R Martino; G Orti; A Esquirol; S Perez-Hoyos; J Sierra; D Valcárcel
Journal:  Bone Marrow Transplant       Date:  2015-06-22       Impact factor: 5.483

5.  Impact of CR before and after allogeneic and autologous transplantation in multiple myeloma: results from the EBMT NMAM2000 prospective trial.

Authors:  S Iacobelli; L C de Wreede; S Schönland; B Björkstrand; U Hegenbart; A Gruber; H Greinix; L Volin; F Narni; A M Carella; M Beksac; A Bosi; G Milone; P Corradini; K Friberg; A van Biezen; H Goldschmidt; T de Witte; C Morris; D Niederwieser; L Garderet; N Kröger; G Gahrton
Journal:  Bone Marrow Transplant       Date:  2015-01-26       Impact factor: 5.483

6.  Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia.

Authors:  Jayakumar Vadakekolathu; Mark D Minden; Tressa Hood; Sarah E Church; Stephen Reeder; Heidi Altmann; Amy H Sullivan; Elena J Viboch; Tasleema Patel; Narmin Ibrahimova; Sarah E Warren; Andrea Arruda; Yan Liang; Thomas H Smith; Gemma A Foulds; Michael D Bailey; James Gowen-MacDonald; John Muth; Marc Schmitz; Alessandra Cesano; A Graham Pockley; Peter J M Valk; Bob Löwenberg; Martin Bornhäuser; Sarah K Tasian; Michael P Rettig; Jan K Davidson-Moncada; John F DiPersio; Sergio Rutella
Journal:  Sci Transl Med       Date:  2020-06-03       Impact factor: 17.956

7.  Factors predicting outcome after allogeneic transplant in refractory acute myeloid leukemia: a retrospective analysis of Gruppo Italiano Trapianto di Midollo Osseo (GITMO).

Authors:  E Todisco; F Ciceri; C Boschini; F Giglio; A Bacigalupo; F Patriarca; I Donnini; E P Alessandrino; W Arcese; A P Iori; P Marenco; I Cavattoni; P Chiusolo; E Terruzzi; L Castagna; A Santoro; A Bosi; E Oldani; B Bruno; F Bonifazi; A Rambaldi
Journal:  Bone Marrow Transplant       Date:  2017-01-09       Impact factor: 5.483

Review 8.  Survival analysis in hematologic malignancies: recommendations for clinicians.

Authors:  Julio Delgado; Arturo Pereira; Neus Villamor; Armando López-Guillermo; Ciril Rozman
Journal:  Haematologica       Date:  2014-09       Impact factor: 9.941

9.  Fungal and viral infections after allogeneic hematopoietic transplantation from unrelated donors in adults: improving outcomes over time.

Authors:  R Parody; R Martino; R de la Cámara; A García-Noblejas; A Esquirol; I Garcia-Cadenas; T Villaescusa; D Caballero; M Rovira; F Fernandez-Avilés; F J Marquez-Malaver; I Espigado; C Castilla-Llorente; I Heras; M A Cabero; J R Cabrera; P Barba; D Valcarcel; I Sánchez-Ortega; R F Duarte; D Serrano; F Carretero; L Vazquez
Journal:  Bone Marrow Transplant       Date:  2014-10-27       Impact factor: 5.483

Review 10.  Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.

Authors:  Jeremy Franklin; Dennis A Eichenauer; Ingrid Becker; Ina Monsef; Andreas Engert
Journal:  Cochrane Database Syst Rev       Date:  2017-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.